- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03813849
Remnants of Conception After Suction Evacuation of Missed Abortion
October 25, 2019 updated by: Mervat Sheikhelarab Elsedeek Ibrahim Omran, University of Alexandria
Sonographic Detection of Remnants After Surgical Evacuation of Missed Abortion
All women admitted for surgical evacuation of missed abortion after failure of medical treatment from June 2016 underwent transvaginal sonography immediately after completion of the procedure as judged by the operator to ensure absence of remnants.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Women indicated for surgical evacuation of missed abortion up to 12 weeks were included.
Standard surgical evacuation of uterus by suction followed by sharp curettage under general anaesthesia were done for all cases.
When the operator judged the procedure as complete, transvaginal sonography was done by dedicated sonographer using portable ultrasound machine in theatre.
If remnants were detected the procedure was repeated till the cavity seen empty.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mervat S Omran, M.D
- Phone Number: +2034226106
- Email: Mervat.Elsedeek@alexmed.edu.eg
Study Locations
-
-
-
Alexandria, Egypt, 03312
- Recruiting
- Shatby Maternity University Hospital
-
Contact:
- Mervat S Omran, M.D
- Phone Number: 1005277168
- Email: Mervat.Elsedeek@alexmed.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
multiparous women, aged 18 to 45 years with missed abortion up to 12 weeks gestational age, with normal uterus and without suspicion of sepsis.
Description
Inclusion Criteria:
multiparous. have missed abortion up to 12 weeks gestational age by dating. failed medical evacuation. consented for the procedure.
Exclusion Criteria:
suspicion of sepsis. Suspected molar pregnancy. previous evacuation trial. abnormal uterus like fibroids.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
presence remnants of conception
Time Frame: immediately after the end of the procedure
|
transvaginal sonographic detection
|
immediately after the end of the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2016
Primary Completion (Anticipated)
January 30, 2020
Study Completion (Anticipated)
March 30, 2020
Study Registration Dates
First Submitted
April 9, 2018
First Submitted That Met QC Criteria
January 22, 2019
First Posted (Actual)
January 23, 2019
Study Record Updates
Last Update Posted (Actual)
October 28, 2019
Last Update Submitted That Met QC Criteria
October 25, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0409/016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Miscarriage
-
Konya Meram State HospitalNot yet recruiting
-
Ain Shams UniversityCompletedThreatened Miscarriage in First Trimester
-
Ain Shams UniversityCompletedComplete MiscarriageEgypt
-
Fudan UniversityUnknown
-
Omar Mamdouh ShaabanUnknown
-
The University of Hong KongCompleted
-
hany faroukNot yet recruiting
-
hany faroukNot yet recruiting
-
Heilongjiang University of Chinese MedicineRecruitingThreatened MiscarriageChina
-
University of BirminghamKing's College Hospital NHS Trust; University College London Hospitals; University... and other collaboratorsCompletedMissed MiscarriageUnited Kingdom
Clinical Trials on Sonographic examination of uterus after surgical evacuation
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Assiut UniversityNot yet recruitingExtradural Hematoma
-
Assiut UniversityNot yet recruitingBasal Ganglionic Hemorrhage
-
Paradigm SpineMCRA; MDT Medical Device Testing GmbHCompleted
-
Dartmouth-Hitchcock Medical CenterCompletedChronic Subdural Hematoma | Subdural HematomaUnited States
-
Centre Hospitalier Universitaire de NiceCompleted
-
Riyadh Colleges of Dentistry and PharmacyNot yet recruitingAlveolar OsteitisSaudi Arabia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Assiut UniversityNot yet recruiting
-
Ohio State University Comprehensive Cancer CenterCompletedTongue Cancer | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous Carcinoma | Stage 0 Lip and Oral Cavity CancerUnited States